HemoPill for Upper GI Bleeding
Phase-Based Progress Estimates
Effectiveness
Safety
NYU Langone Health, New York, NY
Upper GI Bleeding+1 More
HemoPill - DeviceEligibility
18+
All Sexes
What conditions do you have?
Select
Eligibility
18+
All Sexes
What conditions do you have?
Select
Study Summary
This trial is testing a new pill that has a built in sensor to detect if there is bleeding in the upper digestive tract. The information from the sensor is then transmitted to medical personnel. HemoPill is used to treat Upper GI Bleeding and has been previously approved by the FDA for a different condition. No patients in this trial will receive a placebo.
Eligible Conditions
- Upper GI Bleeding
Treatment Effectiveness
Effectiveness Progress
Study Objectives
4 Primary · 0 Secondary · Reporting Duration: 1 hour after endoscopy procedure
Hour 1
Number of False negative results
Number of False positive results
Number of True negative results
Number of True positive results
Trial Safety
Safety Progress
Trial Design
1 Treatment Group
HemoPIll group
1 of 1
Experimental Treatment
50 Total Participants · 1 Treatment Group
Primary Treatment: HemoPill · No Placebo Group · N/A
HemoPIll group
Device
Experimental Group · 1 Intervention: HemoPill · Intervention Types: DeviceTrial Logistics
Trial Timeline
Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: 1 hour after endoscopy procedure
Closest Location: NYU Langone Health · New York, NY
2020First Recorded Clinical Trial
1 TrialsResearching Upper GI Bleeding
110 CompletedClinical Trials
Who is running the clinical trial?
NYU Langone HealthLead Sponsor
1,236 Previous Clinical Trials
749,969 Total Patients Enrolled
Melissa Latorre, MDPrincipal InvestigatorNYU Langone Health
Eligibility Criteria
Age 18+ · All Participants · 4 Total Inclusion Criteria
Mark “yes” if the following statements are true for you:You are scheduled for endoscopy due to suspicion of UGIB based on clinical and / or laboratory findings.
About The Reviewer
Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.
Popular Clinical Trials
Top Clinical Trials in Cities
Relevant Clinical Trials
Unbiased Results
We believe in providing patients with all the options.Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.Back to top
Conditions
Cancer Related
Treatments